Global Thrombectomy Apparatus Market Size By Type (Neurovascular, Artery), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Thrombectomy Apparatus Market was valued at USD 1.4 billion in 2023 and is projected to reach USD 2.9 billion by 2031, growing at a CAGR of 9.5% during the forecast period from 2023 to 2031. The increasing prevalence of cardiovascular diseases, growing geriatric population, and advancements in medical device technology are the key drivers of the market. Thrombectomy apparatus are essential in the removal of blood clots from arteries and veins, playing a crucial role in preventing strokes, pulmonary embolisms, and other thrombotic conditions. Rising awareness about minimally invasive procedures and improved patient outcomes are further propelling market growth.

Drivers:

Rising Incidence of Cardiovascular Diseases:

The surge in cardiovascular diseases, such as deep vein thrombosis, ischemic stroke, and pulmonary embolism, is significantly driving the demand for thrombectomy apparatus globally.

Technological Advancements:

Continuous innovations in thrombectomy devices, such as next-generation mechanical thrombectomy systems and aspiration catheters, have improved procedural success rates, thereby boosting market growth.

Increasing Preference for Minimally Invasive Surgeries:

Growing demand for minimally invasive surgical procedures due to quicker recovery time, reduced hospital stay, and lower risk of infection is fostering the adoption of thrombectomy apparatus.

Restraints:

High Procedure and Device Costs:

The cost of thrombectomy procedures and advanced thrombectomy devices can be prohibitive for smaller healthcare facilities and in developing regions, limiting widespread adoption.

Procedural Risks and Complications:

Despite technological improvements, complications such as vessel damage, incomplete clot removal, and bleeding can hinder the market's growth.

Opportunity:

Growth in Emerging Markets:

The expansion of healthcare infrastructure in emerging economies like India, China, and Brazil presents substantial opportunities for market players.

Strategic Collaborations and Product Launches:

Increasing investments in R&D, coupled with partnerships between medical device manufacturers and healthcare providers, are expected to create lucrative growth prospects.

Market by System Type Insights:

Based on system type, the Mechanical Thrombectomy Devices segment held the largest market share in 2023 due to its higher efficacy in clot removal. However, the Aspiration Thrombectomy Devices segment is projected to witness the highest growth rate, driven by their growing adoption in peripheral and neurovascular thrombectomy procedures.

Market by End-use Insights:

Hospitals dominated the global market in 2023, accounting for over 50% of the market share, owing to the availability of advanced surgical infrastructure and specialized medical staff. Ambulatory Surgical Centers (ASCs) are expected to experience the fastest growth during the forecast period due to increasing demand for outpatient procedures.

Market by Regional Insights:

North America held the largest market share in 2023, driven by high healthcare expenditure, advanced healthcare infrastructure, and growing awareness about thrombectomy procedures. Asia-Pacific is anticipated to exhibit the highest CAGR during the forecast period, supported by rising healthcare investments and an increasing prevalence of cardiovascular diseases.

Competitive Scenario:

Key players operating in the Global Thrombectomy Apparatus Market include:

Medtronic plc

Boston Scientific Corporation

Stryker Corporation

Penumbra Inc.

Johnson & Johnson (DePuy Synthes)

AngioDynamics Inc.

Terumo Corporation

Teleflex Incorporated

Edwards Lifesciences Corporation

Merit Medical Systems, Inc.

These companies are actively involved in product development, strategic acquisitions, and expanding their geographic presence to strengthen their market position.

Scope of Work – Global Thrombectomy Apparatus Market

Report Metric Details

Market Size (2023) USD 1.4 Billion

Projected Market Size (2031) USD 2.9 Billion

CAGR (2023-2031) 9.5%

Key Segments by System Type Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, Rheolytic Thrombectomy Devices

Key Segments by End-Use Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics

Leading Region North America

Key Players Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Penumbra Inc., Terumo Corporation

Growth Drivers Rising incidence of cardiovascular diseases, technological advancements in thrombectomy devices, increasing preference for minimally invasive procedures

Opportunities Market expansion in emerging economies, product innovation, strategic collaborations

Key Market Developments:

In March 2023, Medtronic launched its latest aspiration-based thrombectomy device, expanding its peripheral vascular portfolio.

In May 2024, Boston Scientific acquired a thrombectomy technology start-up specializing in neurovascular solutions to strengthen its market presence.

In January 2025, Stryker Corporation announced the launch of a next-generation mechanical thrombectomy system aimed at improving procedural efficiency and patient outcomes.

FAQs:

1. What is the current market size of the Global Thrombectomy Apparatus Market?

The Global Thrombectomy Apparatus Market was valued at USD 1.4 billion in 2023.

2. What is the major growth driver of the Global Thrombectomy Apparatus Market?

The market is driven by the rising incidence of cardiovascular diseases and technological advancements in thrombectomy devices.

3. Which is the largest region during the forecast period in the Global Thrombectomy Apparatus Market?

North America accounted for the largest market share in 2023 and is expected to maintain its dominance during the forecast period.

4. Which segment accounted for the largest market share in the Global Thrombectomy Apparatus Market?

The Mechanical Thrombectomy Devices segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Thrombectomy Apparatus Market?

Key players include Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Penumbra Inc., and Terumo Corporation.